New techniques circumvent a roadblock to the production of embryonicstem-cell-like lines from adult tissue. Such reprogrammed cell lines should be much safer to use for therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Takahashi, K. & Yamanaka, S. Cell 126, 663–676 (2006).
Woltjen, K. et al. Nature 458, 766–770 (2009).
Kaji, K. et al. Nature 458, 771–775 (2009).
Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Science 322, 945–949 (2008).
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Science 322, 949–953 (2008).
Takahashi, K. et al. Cell 131, 861–872 (2007).
Yu, J. et al. Science 318, 1917–1920 (2007).
Okita, K., Ichisaka, T. & Yamanaka, S. Nature 448, 313–317 (2007).
Zhou, Q. & Melton, D. A. Cell Stem Cell 3, 382–388 (2008).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pera, M. Low-risk reprogramming. Nature 458, 715–716 (2009). https://doi.org/10.1038/458715a
Published:
Issue Date:
DOI: https://doi.org/10.1038/458715a
